GPR120 agonists for the treatment of type 2 diabetes: an updated patent review (2020-present)
{{output}}
Introduction: Type 2 diabetes mellitus (T2DM) affects over 530 million individuals globally and is projected to reach 783 million by 2045, necessitating novel therapeutic strategies beyond current options. G-protein-coupled recep... ...
